MedTrace Logo

Study of the Effect of Different Fish Oils on Omega-3 Index (CetoIndex)

NCT04768595 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2021-02-24

No results posted yet for this study

Summary

The study determines the EPA DHA uptake from different omega-3 supplements against a control.

Conditions

  • Healthy Volunteers

Interventions

DIETARY_SUPPLEMENT

Placebo

Two, 1g capsules taken daily with food

DIETARY_SUPPLEMENT

Ceto 10

Two, 1g capsules daily with food

DIETARY_SUPPLEMENT

Fish oil

Two, 1g capsules daily with food

Sponsors & Collaborators

  • Møreforsking AS

    collaborator OTHER

  • Epax Norway AS

    lead INDUSTRY

Principal Investigators

  • Lisa Midtbø, PhD · Møreforsking AS

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-03
Primary Completion
2021-06-30
Completion
2021-08-01

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04768595 on ClinicalTrials.gov